Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus

Daniel E. Dulek, John V. Williams, C. Buddy Creech, Alynna K. Schulert, Haydar Frangoul, Jennifer Domm, Mark R. Denison, James D. Chappell

Clinical Infectious Diseases · 2010 · 64 citations · 8 references

Concepts

Abstract

Immunosuppressed patients receiving oseltamivir for 2009 novel H1N1 influenza A infection may develop drug resistance, leading to treatment failure. Intravenous zanamivir was administered on a compassionate-use basis to a profoundly immunosuppressed pediatric patient with severe oseltamivir-resistant novel H1N1 pneumonia. The regimen was well tolerated and was associated with a decrease in viral burden.

References

8